These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6483501)

  • 1. Tolazoline pharmacokinetics in lambs.
    Ward RM; Daniel CH; Willes SR; Gallaher KJ
    Pediatr Pharmacol (New York); 1984; 4(2):101-7. PubMed ID: 6483501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oliguria and tolazoline pharmacokinetics in the newborn.
    Ward RM; Daniel CH; Kendig JW; Wood MA
    Pediatrics; 1986 Mar; 77(3):307-15. PubMed ID: 3951911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer.
    Biesma B; Pokorny R; Kovarik JM; Duffy FA; Willemse PH; Mulder NH; de Vries EG
    Cancer Res; 1993 Dec; 53(24):5915-9. PubMed ID: 8261403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age.
    Gauntlett IS; Fisher DM; Hertzka RE; Kuhls E; Spellman MJ; Rudolph C
    Anesthesiology; 1988 Nov; 69(5):683-7. PubMed ID: 3189915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent pharmacokinetics and metabolism of valproic acid in newborn lambs and adult sheep.
    Wong H; Rurak DW; Kumar S; Kwan E; Abbott FS; Riggs KW
    Drug Metab Dispos; 2001 May; 29(5):664-75. PubMed ID: 11302932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
    Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
    Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotracheal tolazoline: pharmacokinetics and pharmacodynamics in dogs.
    Paret G; Eyal O; Mayan H; Gilad E; Ben-Abraham R; Ezra D; Barzilay Z
    Acta Paediatr; 1999 Sep; 88(9):1020-3. PubMed ID: 10519347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and physiological effects of two intravenous infusion rates of morphine in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Jun; 30(3):224-33. PubMed ID: 17472654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary response to dopamine in chronically catheterized neonatal lambs.
    Drummond WH; Webb IB; Purcell KA
    Pediatr Pharmacol (New York); 1981; 1(4):347-56. PubMed ID: 7346751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of persistent fetal circulation syndrome of the newborn. Comparison of different doses of tolazoline.
    Monin P; Dubruc C; Vert P; Morselli PL
    Eur J Clin Pharmacol; 1987; 31(5):569-73. PubMed ID: 3104058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.
    Erlichman C; Moore M; Thiessen JJ; Kerr IG; Walker S; Goodman P; Bjarnason G; DeAngelis C; Bunting P
    Cancer Res; 1993 Oct; 53(20):4837-42. PubMed ID: 8402670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of phenolsulfonphthalein in sheep.
    Danielson TJ; Taylor WG
    Am J Vet Res; 1993 Dec; 54(12):2179-83. PubMed ID: 8116957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of sulfamerazine and antipyrine in neonatal and young lambs.
    De Backer P; Belpaire FM; Bogaert MG; Debackere M
    Am J Vet Res; 1982 Oct; 43(10):1744-51. PubMed ID: 7149373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of rafoxanide in suckling and weaned lambs following oral administration.
    Swan GE; Mülders MS
    J S Afr Vet Assoc; 1993 Jun; 64(2):67-70. PubMed ID: 8410945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
    Chism JP; Rickert DE
    Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.
    Wade M; Baker FJ; Roscigno R; DellaMaestra W; Arneson CP; Hunt TL; Lai AA
    J Clin Pharmacol; 2004 May; 44(5):503-9. PubMed ID: 15102871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition kinetics of human epidermal growth factor (hEGF1-53) and its truncated fragment (hEGF1-48) in rats.
    Kuo BS; Nordblom GD; Dudeck RC; Kirkish LS; Wright DS
    Drug Metab Dispos; 1996 Jan; 24(1):96-104. PubMed ID: 8825196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.